| Bioactivity | SHLP-6 is a mitochondrial-derived peptide, a biologically active microprotein encoded by the 16S ribosomal RNA (MT-RNR2) gene. SHLP6 increases apoptosis in insulinoma cells NIT1 and human prostate cancer cell 22Rv1. SHLP6 can be used in the study of diabetes and cancer[1]. |
| CAS | 368431-25-8 |
| Sequence | Met-Leu-Asp-Gln-Asp-Ile-Pro-Met-Val-Gln-Pro-Leu-Leu-Lys-Val-Arg-Leu-Phe-Asn-Asp |
| Shortening | MLDQDIPMVQPLLKVRLFND |
| Formula | C107H177N27O30S2 |
| Molar Mass | 2385.84 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Satadeepa Kal, et al. "Mitochondrial-derived peptides: Antidiabetic functions and evolutionary perspectives." Peptides (2023): 171147. |
SHLP-6
CAS: 368431-25-8 F: C107H177N27O30S2 W: 2385.84
SHLP-6 is a mitochondrial-derived peptide, a biologically active microprotein encoded by the 16S ribosomal RNA (MT-RNR2)
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.